Mainstream

Travere Therapeutics Non-GAAP EPS of -$0.47 misses by $0.09, revenue of $74.79M beats by $2.41M

Travere Therapeutics Non-GAAP EPS of -$0.47 misses by $0.09, revenue of $74.79M beats by $2.41M

Post ContenttvtxRead More

You might also be interested in reading Dogecoin Is A ‘Client-Statement Risk’ For Advisers, ETF Experts Say.

February 20, 2025
In Mainstream